{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:21:39Z","timestamp":1761016899994,"version":"3.38.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.pbb.2011.02.007","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T12:06:33Z","timestamp":1298721993000},"page":"552-558","source":"Crossref","is-referenced-by-count":13,"title":["L-DOPA attenuates nicotine withdrawal-induced behaviors in rats"],"prefix":"10.1016","volume":"98","author":[{"given":"Yu","family":"Ohmura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Jutkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Domino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2000","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.pbb.2011.02.007_bb0005"},{"issue":"8","key":"10.1016\/j.pbb.2011.02.007_bb0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/syn.20535","article-title":"Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter","volume":"62","author":"Arai","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2011.02.007_bb0015","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/clpt.1982.233","article-title":"Circadian blood nicotine concentrations during cigarette smoking","volume":"32","author":"Benowitz","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2011.02.007_bb0020","first-page":"CD005353","article-title":"Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation","volume":"4","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pbb.2011.02.007_bb0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-003-1492-0","article-title":"Hypericum perforatum attenuates nicotine withdrawal signs in mice","volume":"169","author":"Catania","year":"2003","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pbb.2007.04.012","article-title":"C57BL\/6J mice show greater amphetamine-induced locomotor activation and dopamine efflux in the striatum than 129S2\/SvHsd mice","volume":"87","author":"Chen","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.007_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(25)22727-6","article-title":"Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion","volume":"271","author":"Collins","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.007_bb0040","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14622200412331324938","article-title":"The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations","volume":"6","author":"Colrain","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pbb.2011.02.007_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-3223(02)01730-4","article-title":"Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents","volume":"34","author":"Cryan","year":"2003","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.pbb.2011.02.007_bb0045","doi-asserted-by":"crossref","first-page":"R399","DOI":"10.1152\/ajpregu.00386.2002","article-title":"Central nervous system effects of caffeine and adenosine on fatigue","volume":"284","author":"Davis","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2009.02.011","article-title":"Nicotine sensitization of monkey striatal dopamine release","volume":"607","author":"Domino","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biopsych.2005.03.038","article-title":"Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa","volume":"58","author":"Eltayb","year":"2005","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.pbb.2011.02.007_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0091-3057(01)00642-6","article-title":"Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration","volume":"70","author":"Faraday","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.007_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-4328(00)00201-1","article-title":"Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice","volume":"113","author":"G\u00e4ddn\u00e4s","year":"2000","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.007_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/ajp.156.1.130","article-title":"Low CSF concentration of dopamine metabolite in tobacco smokers","volume":"156","author":"Geracioti","year":"1999","journal-title":"Am J Psychiat"},{"key":"10.1016\/j.pbb.2011.02.007_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pbb.2008.10.010","article-title":"Behavioral effects of nicotine withdrawal in adult male and female rats","volume":"92","author":"Hamilton","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"10.1016\/j.pbb.2011.02.007_bb0085","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ntr\/ntq179","article-title":"Behavioral effects of nicotine withdrawal differ by genetic strain in male and female adolescent rats","volume":"12","author":"Hamilton","year":"2010","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pbb.2011.02.007_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02245698","article-title":"Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity","volume":"113","author":"Helton","year":"1993","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0006-8993(97)01135-9","article-title":"Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome","volume":"779","author":"Hildebrand","year":"1998","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.007_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/14622200701188927","article-title":"Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pbb.2011.02.007_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2008.06.003","article-title":"Smoking and suicide: a brief overview","volume":"98","author":"Hughes","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2011.02.007_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14622200050011321","article-title":"Carbidopa\/levodopa for smoking cessation: a pilot study with negative results","volume":"2","author":"Hurt","year":"2000","journal-title":"Nicotine Tob Res"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2011.02.007_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2005.12.002","article-title":"Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects","volume":"531","author":"Jutkiewicz","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/jpet.107.123844","article-title":"The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N, N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats","volume":"324","author":"Jutkiewicz","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2011.02.007_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2006.03.059","article-title":"Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters","volume":"402","author":"Kannari","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.02.007_bb0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2009.04.035","article-title":"The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease","volume":"203","author":"Kelsey","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.007_bb0135","article-title":"Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats","author":"Kompagne","year":"2008","journal-title":"World Health Organization"},{"key":"10.1016\/j.pbb.2011.02.007_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0091-3057(01)00775-4","article-title":"Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h\/day access to nicotine","volume":"72","author":"LeSage","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.007_bb0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-3-540-69248-5_14","article-title":"Rodent models of nicotine withdrawal syndrome","volume":"192","author":"Malin","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(92)90408-8","article-title":"Rodent model of nicotine abstinence syndrome","volume":"43","author":"Malin","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.007_bb0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00213-005-0135-z","article-title":"Bupropion attenuates nicotine abstinence syndrome in the rat","volume":"184","author":"Malin","year":"2006","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuint.2006.03.010","article-title":"Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke","volume":"49","author":"Mannucci","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pbb.2011.02.007_bb0165","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1523\/JNEUROSCI.12-07-02765.1992","article-title":"Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment","volume":"12","author":"Marks","year":"1992","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.pbb.2011.02.007_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.braindev.2009.09.008","article-title":"Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A","volume":"32","author":"Miyata","year":"2010","journal-title":"Brain Dev"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2011.02.007_bb0175","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0387-7604(03)90007-6","article-title":"Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis","volume":"25","author":"Nomura","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.pbb.2011.02.007_bb0180","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF02244248","article-title":"Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats","volume":"103","author":"Paulson","year":"1991","journal-title":"Psychopharmacol"},{"issue":"5604","key":"10.1016\/j.pbb.2011.02.007_bb0185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.02.007_bb0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0195","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.64.3.619","article-title":"L-DOPA treatment modulates nicotinic receptors in monkey striatum","volume":"64","author":"Quik","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s002130100781","article-title":"Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens","volume":"157","author":"Rada","year":"2001","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.007_bb0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuroscience.2004.08.010","article-title":"Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study","volume":"129","author":"Rahman","year":"2004","journal-title":"Neurosci"},{"key":"10.1016\/j.pbb.2011.02.007_bb0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.npep.2008.03.004","article-title":"Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats","volume":"42","author":"Rylkova","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2011.02.007_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(25)31831-8","article-title":"Effects of L-dopa and L-5-hydroxytryptophan on locomotor activity of the rat after selective or combined destruction of central catecholamine and serotonin neurons","volume":"211","author":"Schlosberg","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.007_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0361-9230(97)00332-8","article-title":"Effects of nicotine and footshock stress on dopamine release in the striatum and nucleus accumbens","volume":"45","author":"Takahashi","year":"1998","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2011.02.007_bb0225","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.0602371103","article-title":"A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice","volume":"103","author":"Takayasu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.02.007_bb0230","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1471-4159.1994.63010108.x","article-title":"L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors","volume":"63","author":"Wachtel","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.02.007_bb0235","series-title":"Diagnostic criteria for research. Geneva, Switzerland: World Health Organization","article-title":"The ICD-10 classification of mental and behavioural disorders","author":"World Heatlh Organization","year":"1993"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:14:43Z","timestamp":1740964483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0091305711000463"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.02.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}